Before anyone starts claiming that another biopharma just pulled ahead of NNVC, I think it's important to read this part:
"Schmaljohn cautioned that the drugs were given within an hour after infection and that they could be much less effective later in the course of the disease or against a more aggressive strain of the viruses."
An hour after infection? I'm no virologist, but...anyone in that field in the audience who might want to chime in here?
Market Data 
Markets 
AI
